Omeprazole Safety With Common Cardiometabolic Medications
Omeprazole is generally safe to take with metformin, losartan, amlodipine, carvedilol, and isosorbide when the regimen does not include clopidogrel or other key interacting drugs. [1]
The primary labeled drug-drug interaction concern is reduced antiplatelet effect with clopidogrel due to CYP2C19 inhibition. [1]
Core Interaction Risk
Omeprazole inhibits CYP2C19. [1]
Avoidance is specifically recommended for concomitant use of omeprazole with clopidogrel because conversion of clopidogrel to its active metabolite can be impaired. [1]
Concomitant use of omeprazole with clopidogrel is associated with reduced platelet inhibition. [1]
Interaction Screening for the Listed Medications
No labeled clinically important interaction is specifically highlighted in the omeprazole prescribing information for metformin, losartan, amlodipine, carvedilol, isosorbide products (mononitrate or dinitrate), or atorvastatin in the provided interaction tables/sections. [1]
Ongoing Therapy Safety Considerations
Long-term proton pump inhibitor therapy is associated with risk of vitamin B12 deficiency due to malabsorption from reduced gastric acidity. [1]
Hypomagnesemia is reported with proton pump inhibitor therapy, including cases that require magnesium replacement and discontinuation of the PPI. [1]
Monitoring magnesium levels prior to initiation and periodically is stated as a consideration for patients expected to be on prolonged therapy or receiving drugs associated with hypomagnesemia risk (for example, some diuretics). [1]
Practical Administration and Monitoring
If clopidogrel is part of the regimen, omeprazole should not be co-administered with it and an alternative antiplatelet strategy should be considered. [1]
If prolonged omeprazole therapy is anticipated, vitamin B12 deficiency and hypomagnesemia risk should be considered. [1]
When Additional Clinical Review Is Needed
Additional medication review is needed for potential interactions with drugs that are CYP2C19 substrates where omeprazole may reduce activation or effect. [1]
Additional clinical review is needed for symptoms suggestive of electrolyte or vitamin deficiencies during extended therapy (for example, neurologic symptoms consistent with B12 deficiency or symptoms suggestive of hypomagnesemia). [1]
Drug Safety Bottom Line
Omeprazole is generally safe with the listed blood-pressure and cardiac antianginal regimen and with metformin unless clopidogrel is also being taken. [1]
Long-term use should prompt consideration of monitoring for vitamin B12 deficiency and hypomagnesemia risk. [1]